Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 10611744 Highly purified pharmaceutical grade tasimelteon
Overview
Structured Data
Issues
Contributors
Activity
All edits
Edits on 12 Mar, 2024
"update inverses"
Golden AI
edited on 12 Mar, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 11918557 Treatment of circadian rhythm disorders
0
"update inverses"
Golden AI
edited on 12 Mar, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 11918556 Treatment of circadian rhythm disorders
0
Edits on 27 Dec, 2023
"update inverses"
Golden AI
edited on 27 Dec, 2023
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 11850229 Treatment of circadian rhythm disorders
0
Edits on 7 Dec, 2023
"update inverses"
Golden AI
edited on 7 Dec, 2023
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 11833130 Treatment of circadian rhythm disorders
0
Edits on 18 Oct, 2023
"update inverses"
Golden AI
edited on 18 Oct, 2023
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 11786502 Method of treatment
Edits on 30 Apr, 2023
"update inverses"
Golden AI
edited on 30 Apr, 2023
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 11633377 Treatment of circadian rhythm disorders
0
Edits on 29 Apr, 2023
"Entity importer update"
Golden AI
edited on 29 Apr, 2023
Infobox
Is a
Patent
0
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
10611744
0
Date of Patent
April 7, 2020
0
Patent Application Number
16123303
0
Date Filed
September 6, 2018
0
Patent Citations Received
US Patent 11285129 Treatment of circadian rhythm disorders
0
Patent Primary Examiner
Timothy R Rozof
0
Edits on 22 Apr, 2023
"update citations for inverse infoboxes"
Golden AI
edited on 22 Apr, 2023
Infobox
Patent Citations Received
US Patent 11285129 Treatment of circadian rhythm disorders
0
Edits on 30 Mar, 2022
"update inverses"
Golden AI
edited on 30 Mar, 2022
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent citations received
US Patent 11285129 Treatment of circadian rhythm disorders
Edits on 2 Feb, 2022
"Created via: Entity Importer"
Golden AI
created this topic on 2 Feb, 2022
Edits made to:
Infobox
(
+7
properties)
US Patent 10611744 Highly purified pharmaceutical grade tasimelteon
Infobox
Is a
Patent
Patent jurisdiction
United States Patent and Trademark Office
Patent number
10611744
Date of patent
April 7, 2020
Patent application number
16123303
Date Filed
September 6, 2018
Patent primary examiner
Timothy R Rozof
Find more entities like US Patent 10611744 Highly purified pharmaceutical grade tasimelteon
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE